The de novo ASC market is being reshaped by population shifts, site-of-service changes and the growing push toward value-based care, according to Leawood, Kan.-based NueHealth founder and chairman Dan Tasset. As many existing ASCs struggle to adapt to new cost and care delivery models, de novo development is increasingly driven by the need for redesigned […]
